Total Payments
$2,161
2024 Payments
$757.42
Companies
16
Transactions
113
Medicare Patients
1,845
Medicare Billing
$77,445
Payment Breakdown by Category
Food & Beverage$1,968 (91.1%)
Education$193.03 (8.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,968 | 111 | 91.1% |
| Education | $193.03 | 2 | 8.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $472.47 | 35 | $0 (2024) |
| ABBVIE INC. | $450.07 | 29 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $261.99 | 9 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $174.36 | 6 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $172.82 | 5 | $0 (2023) |
| Incyte Corporation | $113.80 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $93.97 | 3 | $0 (2024) |
| Lilly USA, LLC | $86.68 | 4 | $0 (2024) |
| Amgen Inc. | $81.44 | 3 | $0 (2024) |
| UCB, Inc. | $53.44 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $757.42 | 36 | Novartis Pharmaceuticals Corporation ($287.59) |
| 2023 | $545.41 | 30 | Novartis Pharmaceuticals Corporation ($131.09) |
| 2022 | $544.31 | 22 | Regeneron Healthcare Solutions, Inc. ($140.99) |
| 2021 | $314.34 | 25 | AbbVie Inc. ($145.97) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 3 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/12/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/28/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: IMMUNOLOGY | ||||||
| 06/15/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $11.18 | General |
| 06/14/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $7.20 | General |
| 06/09/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/23/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $9.81 | General |
| 04/27/2023 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Dermatology | ||||||
| 04/04/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $18.29 | General |
| 03/29/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $33.98 | General |
| Category: IMMUNOLOGY | ||||||
| 02/23/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $52.15 | General |
| Category: DERMATOLOGY | ||||||
| 02/14/2023 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 02/08/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: IMMUNOLOGY | ||||||
| 02/07/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $11.02 | General |
| 01/31/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.06 | General |
| Category: Dermatology | ||||||
| 01/25/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: IMMUNOLOGY | ||||||
| 01/23/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $9.80 | General |
| 12/21/2022 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.22 | General |
| Category: Immunology | ||||||
| 12/21/2022 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $13.00 | General |
| 12/20/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Immunology | ||||||
| 11/01/2022 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Immunology | ||||||
| 10/26/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/18/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Inflammation | ||||||
| 09/20/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 398 | 613 | $69,783 | $15,238 |
| 2022 | 8 | 415 | 674 | $74,060 | $20,551 |
| 2021 | 11 | 580 | 1,081 | $98,411 | $23,424 |
| 2020 | 8 | 452 | 848 | $79,650 | $18,232 |
Total Patients
1,845
Total Services
3,216
Medicare Billing
$77,445
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 115 | $20,125 | $4,539 | 22.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 45 | 49 | $11,221 | $2,576 | 23.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 68 | 80 | $11,040 | $2,375 | 21.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 49 | 49 | $10,878 | $2,127 | 19.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 37 | 37 | $7,400 | $1,332 | 18.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 56 | 237 | $2,844 | $928.56 | 32.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 21 | 21 | $3,150 | $687.45 | 21.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 25 | $3,125 | $673.77 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 107 | 133 | $21,425 | $6,587 | 30.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 54 | 58 | $13,282 | $3,723 | 28.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 54 | 54 | $11,988 | $3,426 | 28.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 73 | 86 | $11,868 | $2,527 | 21.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 42 | 44 | $8,800 | $2,247 | 25.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 57 | 271 | $3,252 | $1,031 | 31.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 17 | $1,775 | $527.40 | 29.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 11 | 11 | $1,670 | $482.38 | 28.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 121 | 150 | $22,500 | $6,244 | 27.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 72 | 72 | $15,984 | $3,675 | 23.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 63 | 66 | $13,200 | $3,240 | 24.5% |
| 17000 | Destruction of skin growth | Office | 2021 | 105 | 119 | $16,422 | $3,078 | 18.7% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 53 | 55 | $12,595 | $2,863 | 22.7% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 77 | 418 | $5,016 | $1,409 | 28.1% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 13 | 13 | $4,030 | $1,095 | 27.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 28 | 32 | $2,880 | $908.70 | 31.6% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 21 | 21 | $3,234 | $745.17 | 23.0% |
About Chelsea Miller, PA-C
Chelsea Miller, PA-C is a Physician Assistant healthcare provider based in Meridian, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2013. The National Provider Identifier (NPI) number assigned to this provider is 1043659196.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Chelsea Miller, PA-C has received a total of $2,161 in payments from pharmaceutical and medical device companies, with $757.42 received in 2024. These payments were reported across 113 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,968).
As a Medicare-enrolled provider, Miller has provided services to 1,845 Medicare beneficiaries, totaling 3,216 services with total Medicare billing of $77,445. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Meridian, ID
- Active Since 06/21/2013
- Last Updated 07/07/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1043659196
Products in Payments
- DUPIXENT (Biological) $286.93
- SKYRIZI (Biological) $276.60
- COSENTYX (Drug) $219.93
- OPZELURA (Drug) $113.80
- OPDIVO (Biological) $88.30
- HUMIRA (Biological) $87.33
- Sotyktu (Drug) $86.06
- Otezla (Drug) $81.44
- SPEVIGO (Drug) $68.42
- TALTZ (Drug) $62.77
- UBRELVY (Drug) $56.90
- ADBRY (Biological) $52.15
- AKLIEF (Drug) $47.35
- COSENTYX (Biological) $40.79
- ILUMYA (Biological) $40.26
- EUCRISA (Drug) $39.71
- Ilumya (Biological) $32.57
- Cimzia (Drug) $29.52
- QULIPTA (Drug) $29.24
- CYLTEZO (Drug) $25.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Meridian
Mr. Arthur Nease, Pa-C, PA-C
Physician Assistant — Payments: $14,882
Physician Assistant $14,882
Mr. Alexander Arhets, Pa-C, PA-C
Physician Assistant — Payments: $10,051
Physician Assistant $10,051
Jeremy Frix, Pa, PA
Physician Assistant — Payments: $9,113
Physician Assistant $9,113
David Barclay, Pa-C, PA-C
Physician Assistant — Payments: $7,557
Physician Assistant $7,557
Austin Lee, P.a, P.A
Physician Assistant — Payments: $5,397
Physician Assistant $5,397
Katherine Smalley, Pa-C, PA-C
Physician Assistant — Payments: $5,148
Physician Assistant $5,148